drugset / Trial / NCT01493856
A Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Combination of Rosuvastatin and CS-866 and DWJ1276
RandomizedCrossoverOpen-label
Summary
The purpose of this study is to evaluate the safety and pharmacokinetic characteristics of combination of rosuvastatin and CS-866 and DWJ1276 alone.
Timeline
- Start
- 2012-01
- Primary completion
- 2012-02
- Completion
- 2012-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Olmesartan medoxomil | Unknown | 40 mg | — |
| Comparator | Rosuvastatin | Small molecule | 20 mg | — |
Indications
No indication recorded.